Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1378/chest.10-2607 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
High Interleukin (IL)-6 is Associated with Lower Lung Function and Increased Likelihood of Metabolic Dysfunction in Asthma.
Pulm Ther
December 2024
Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.
Introduction: Asthma is a complex condition characterized by airway inflammation. Interleukin-6 (IL-6) plays a significant role in asthma pathogenesis through its effects on T cells and its association with pro-inflammatory responses. Both lung and circulating IL-6 levels are elevated in asthma.
View Article and Find Full Text PDFPAPVR - An incidental finding that may not be so benign.
Int J Cardiol Congenit Heart Dis
March 2023
Departments of Medicine and Pediatrics, Divisions of Cardiovascular Medicine and Pediatric Cardiology, Stanford University School of Medicine, Stanford, CA, USA.
Partial anomalous pulmonary venous return in adults: Insight into pulmonary hypertension.
Int J Cardiol Congenit Heart Dis
March 2023
Division of Cardiology, Cliniques Universitaires Saint-Luc, Brussels, Belgium.
Background: Partial anomalous pulmonary venous return (PAPVR) is a rare condition that may lead to pulmonary arterial hypertension (PAH). We sought to determine the prevalence of PAPVR, the follow-up rate of incidentally discovered PAPVR, the repercussions of volume and pressure overload on the right ventricle (RV), and the prevalence and predictors of PAH.
Methods And Results: Fifty PAPVR patients aged ≥18 years were included.
Long term clinical outcomes in patients requiring cardiac pacing due to congenital complete heart block.
Int J Cardiol Congenit Heart Dis
September 2022
Adult Congenital Heart Centre and National Centre for Pulmonary Hypertension, Royal Brompton Hospital, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.
Background: Isolated congenital complete heart block (CCHB) is rare cardiac condition associated with maternal Anti-Rho antibodies. It is managed with permanent pacemaker insertion. We sought to determine the long-term outcomes of individuals with CCHB who had undergone pacemaker insertion.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!